Core Viewpoint - Hong Jiu Fruit (stock code: 6689) faces delisting from the Hong Kong Stock Exchange due to failure to meet resumption guidelines, as stated by the Listing Committee on October 3, 2025 [2][3] Group 1: Delisting Decision - The Listing Committee's decision to delist Hong Jiu Fruit is based on incomplete investigations and failure to implement appropriate remedial measures [2] - The company has not demonstrated the integrity, capability, or character of its management, which raises regulatory concerns [3] - Hong Jiu Fruit's board expressed regret over the delisting decision, arguing that the Listing Committee did not adequately consider the evidence submitted by the company [3] Group 2: Criminal Investigations - Chairman Deng Hong Jiu and other key management members are under criminal investigation related to loan fraud and/or issuing false VAT invoices [4][6] - The company has faced operational restrictions since January 6, 2025, due to police investigations, impacting its ability to conduct normal business [6][7] - As of the announcement date, most restrictions have been lifted, allowing the company to gradually resume normal operations, except for the detained executives [7] Group 3: Stock Performance and Investor Impact - Hong Jiu Fruit's stock has been suspended since March 20, 2024, leading to significant losses for investors [9] - The company went public in September 2022 at an issue price of HKD 40, raising a net amount of HKD 497 million, marking it as "China's first fruit stock" [4]

Core Viewpoint - Tianmao Group will officially delist after 29 years of being listed, with its stock set to be delisted on September 30, 2025, following a decision by the Shenzhen Stock Exchange [2][4]. Financial Performance - In 2023, Tianmao Group reported a revenue of 49.699 billion yuan, a slight increase of 0.17% year-on-year, but incurred a net loss of 0.652 billion yuan, reversing from a profit of 0.274 billion yuan in 2022 [2][3]. - The company anticipates continued losses in 2024, projecting revenue between 40 billion and 43 billion yuan, with expected net losses ranging from 0.5 billion to 0.75 billion yuan [2][3]. Business Transition and Challenges - Tianmao Group transitioned from chemical manufacturing to the insurance industry in July 2016, but has faced significant operational challenges in recent years [2]. - The decline in interest rates has adversely affected the company's subsidiary, Guohua Life Insurance, leading to increased reserve provisions that contributed to the losses [3]. Delisting Process - The company has initiated the process to voluntarily delist its shares, with a shareholder meeting approving the decision on August 25, 2025 [4]. - Following the delisting, Tianmao Group's shares will be transferred to the National Equities Exchange and Quotations system for management [2][5]. Shareholder Actions - Tianmao Group has signed an agreement with Changcheng Guorui Securities to facilitate the transfer of shares post-delisting and manage related services [5]. - The company has provided cash options to shareholders, with 1.44 billion cash options effectively declared during the exercise period, allowing shareholders to sell their shares at a price of 1.60 yuan per share [6].

Group 1 - The core viewpoint is that the China Securities Regulatory Commission (CSRC) is focused on strictly eliminating "bad apples" and some shell "zombie" companies from the market [1] - During the 14th Five-Year Plan period, a total of 207 companies have been smoothly delisted [1]

Group 1 - The core viewpoint of the article emphasizes the importance of strict exit channels to eliminate "bad apples" and "zombie" companies in the market [1] - During the "14th Five-Year Plan" period, a total of 207 companies have been smoothly delisted [1]

Core Viewpoint - *ST Tianmao plans to voluntarily delist its A-shares from the Shenzhen Stock Exchange due to difficulties in disclosing its annual report and the first quarter report for 2025 [2][5]. Group 1: Delisting Process - On September 4, *ST Tianmao announced its intention to withdraw its A-shares from trading on the Shenzhen Stock Exchange through a shareholder resolution [2]. - The company had previously disclosed its plan for voluntary delisting on August 8, emphasizing the establishment of mechanisms to protect dissenting shareholders [4]. - The delisting was approved during the company's first extraordinary general meeting in 2025, and the application for delisting was submitted to the Shenzhen Stock Exchange [4]. Group 2: Financial and Regulatory Issues - *ST Tianmao's stock was placed under delisting risk warning on July 8, 2025, due to the failure to disclose the 2024 annual report and the first quarter report for 2025 within the legal timeframe [5]. - If the company fails to disclose more than half of the board members' guarantees for the 2024 annual report within two months of the delisting risk warning, the Shenzhen Stock Exchange will terminate the company's stock listing [5]. - The company is currently under investigation by the China Securities Regulatory Commission for failing to disclose periodic reports on time [5]. Group 3: Company Background - *ST Tianmao was publicly listed in 1996 and underwent a significant change in ownership in 2002 when Liu Yiqian became the actual controller after acquiring the company [5]. - The company transitioned from a pharmaceutical focus to the insurance industry, primarily operating through its subsidiaries Guohua Life and Huarui Insurance [5]. - As of August 13, 2025, *ST Tianmao's stock price was 1.58 yuan per share, with a total market capitalization of 7.7 billion yuan [6].

Core Viewpoint - *ST Tianmao plans to voluntarily delist its A-shares from the Shenzhen Stock Exchange due to difficulties in disclosing its annual report and will apply for transfer to the delisting board managed by the National Equities Exchange and Quotations after the delisting [2][4] Group 1: Delisting Process - On August 8, *ST Tianmao first announced its intention to voluntarily delist its A-shares from the Shenzhen Stock Exchange [4] - The delisting proposal was approved at the company's first extraordinary general meeting in 2025 on August 25, and the company submitted the delisting application to the Shenzhen Stock Exchange [4] - After delisting, *ST Tianmao aims to maintain stable operations and protect shareholders' legal rights, with no plans for major asset restructuring or specific timelines for re-listing [4] Group 2: Reporting Issues - *ST Tianmao failed to disclose its 2024 annual report and the first quarter report for 2025 within the legal timeframe, leading to a delisting risk warning on July 8, 2025 [4][5] - If the company does not disclose more than half of the board's assurance of the 2024 annual report within two months of the delisting risk warning, the Shenzhen Stock Exchange will decide to terminate the company's stock listing [4] Group 3: Company Background - *ST Tianmao was publicly listed in 1996 and underwent a significant change in ownership in 2002 when Liu Yiqian became the actual controller after acquiring the company [5] - The company transitioned from a pharmaceutical focus to the insurance industry, primarily operating through its subsidiaries, Guohua Life and Huarui Insurance [5] - As of August 13, the last trading day, *ST Tianmao's stock price was 1.58 yuan per share, with a total market capitalization of 7.7 billion yuan [5]

Core Insights - As of July 31, 2025, there are a total of 5,427 listed companies in China's domestic stock market, distributed across the Shanghai, Shenzhen, and Beijing stock exchanges with 2,285, 2,873, and 269 companies respectively [1] Company Statistics - Among the listed companies, 5,188 are A-share companies, 8 are B-share companies, and 231 companies have multiple share types such as A+B or A+H [3] - The distribution of companies by ownership shows that state-controlled companies account for 27% while non-state-controlled companies make up 73% [3] Industry Breakdown - The top three industries by the number of listed companies are manufacturing, information transmission/software and IT services, and wholesale and retail, with manufacturing companies representing 68% of the total and accounting for 54% of the market capitalization [3] Market Activity - In July, the domestic market saw 8 new initial public offerings (IPOs) raising a total of 24.164 billion yuan, while 10 companies were delisted, including 9 from the main board [3] - There are currently 1,825 Chinese concept companies listed in major overseas markets [3]

Group 1 - Shenyang Bank announced its plan to delist from the Hong Kong Stock Exchange, with a cash offer of approximately HKD 29.67 billion for all circulating H-shares and HKD 39.29 billion for domestic shares, totaling around RMB 66.52 billion [3] - The offer price represents a significant premium over the last closing price of HKD 1.14 before the suspension, providing a rare exit opportunity for long-term shareholders [3] - Following the announcement, the bank's stock price surged by 11.4% to HKD 1.27 per share, with a market capitalization of HKD 112 billion [3] Group 2 - The bank's reasons for the delisting include optimizing resource allocation, as maintaining a listing incurs costs that could be redirected to business operations [4] - Trading volume for H-shares has been extremely low, with average daily trading volumes representing only about 0.0025% to 0.0345% of total issued H-shares over various periods, limiting effective financing capabilities [4] - The bank's stock price has been underperforming, declining by 4.20% from early 2025 to the suspension, while the Hang Seng Index and the mainland bank index increased by 30.05% and 28.39%, respectively [4] Group 3 - As of the end of the previous year, Shenyang Bank reported a non-performing loan ratio of 2.68%, which is higher than the industry average of 1.5% [6] - The bank's asset impairment losses have significantly decreased from previous years, with losses of RMB 31.2 billion in 2023 and RMB 17.47 billion in 2024 [6] - The bank's total assets reached RMB 11,227.76 billion, a 4% increase year-on-year, while total deposits grew by 2.6% to RMB 7,805.89 billion [6]

Core Viewpoint - *ST Tianmao, controlled by Liu Yiqian, plans to voluntarily delist after facing a risk warning and delays in disclosing its annual report, with the proposal passing at a shareholder meeting with 98.0562% approval [1][9][12]. Group 1: Shareholder Meeting Details - The shareholder meeting lasted over two hours, with significant attendance from minority shareholders, some traveling long distances to participate [1][4]. - Despite concerns raised by minority shareholders regarding the delayed annual report, the company did not provide substantial responses [1][7]. - The proposal for voluntary delisting was approved with 98.0562% of votes in favor, despite some dissenting opinions [1][12]. Group 2: Financial and Operational Context - *ST Tianmao's main business is insurance, primarily through its subsidiaries Guohua Life and Huarui Insurance, which account for 99.99% of its revenue [3]. - The company reported total assets of approximately 285.15 billion yuan, a decrease of 5.56% from the previous year, while the equity attributable to shareholders increased by 5.87% to approximately 21.80 billion yuan [2]. Group 3: Cash Option and Valuation Concerns - The cash option for shareholders is set at 1.60 yuan per share, representing a premium of about 10.34% over the last closing price before the delisting announcement [8]. - Some minority shareholders expressed concerns that the cash option price is significantly lower than the company's net asset value of 4.41 yuan per share, indicating a substantial discount [8].

Core Viewpoint - *ST Tianmao, controlled by Liu Yiqian, plans to voluntarily delist after failing to disclose its annual report and facing delisting risk warnings, with a shareholder meeting held on August 25 to vote on the proposal [1][3]. Group 1: Shareholder Meeting and Voting - The shareholder meeting lasted over two hours, with many minority shareholders traveling long distances to attend, including some from Inner Mongolia [1][6]. - Despite some dissent from minority shareholders regarding the annual report issues, the voluntary delisting proposal was approved with a high vote of 98.0562% [3][10]. - A total of 6,901 shareholders attended the meeting, representing 4.26 billion shares, with 85.64% voting online [8][10]. Group 2: Financial and Operational Context - *ST Tianmao's main business is insurance, with revenue from insurance operations accounting for 99.99% of its main business income [5]. - The company reported a net asset value of 21.8 billion yuan as of the latest quarterly report, with total assets of 285.15 billion yuan, reflecting a decrease of 5.56% from the previous year [4][5]. - The cash option for shareholders is set at 1.60 yuan per share, which is a 10.34% premium over the last trading day's closing price of 1.45 yuan [9][11]. Group 3: Shareholder Concerns and Reactions - Minority shareholders raised concerns about the lack of substantial responses to their questions regarding the delayed annual report and the company's operational status [2][6]. - Some shareholders expressed dissatisfaction with the cash option price, arguing it represents a significant discount compared to the company's net asset value [9][11]. - Following the announcement of the voluntary delisting, some shareholders indicated plans to exercise their rights on part of their holdings, while others chose to sell their shares [11].